{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:21:37Z","timestamp":1760188897411},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1007\/s11912-005-0026-9","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T13:42:31Z","timestamp":1180705351000},"page":"55-60","source":"Crossref","is-referenced-by-count":19,"title":["Metastatic neurologic complications of non-Hodgkin\u2019s lymphoma"],"prefix":"10.1007","volume":"7","author":[{"given":"Jeanine","family":"Grier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy","family":"Batchelor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"26_CR1","unstructured":"Cancer facts and figures 1997. http:\/\/www.cancer.org"},{"key":"26_CR2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1470-2045(04)01490-1","volume":"5","author":"BT Hennessy","year":"2004","unstructured":"Hennessy BT, Hanahan EO, Daly PA: Non-Hodgkin lymphoma: an update. Lancet Oncol 2004, 5:341\u2013353.","journal-title":"Lancet Oncol"},{"key":"26_CR3","unstructured":"Cancer facts and figures 2003. http:\/\/www.cancer.org"},{"key":"26_CR4","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/1097-0142(19820201)49:3<586::AID-CNCR2820490331>3.0.CO;2-C","volume":"49","author":"FR MacKintosh","year":"1982","unstructured":"MacKintosh FR, Colby TV, Podolsky WJ, et al.: Central nervous system involvement in non-Hodgkin\u2019s lymphoma: an analysis of 105 cases. Cancer 1982, 49:586\u2013595.","journal-title":"Cancer"},{"key":"26_CR5","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0959-8049(00)00171-4","volume":"36","author":"A Hollender","year":"2000","unstructured":"Hollender A, Kvaloy S, Lote K, et al.: Prognostic factors in 140 adult patients with non-Hodgkin\u2019s lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis. Eur JCancer 2000, 36:1762\u20131768.","journal-title":"Eur JCancer"},{"key":"26_CR6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/1097-0142(19800201)45:3<545::AID-CNCR2820450322>3.0.CO;2-6","volume":"45","author":"LJ Levitt","year":"1980","unstructured":"Levitt LJ, Dawson DM, Rosenthal DS, et al.: CNS involvement in the non-Hodgkin\u2019s lymphomas. Cancer 1980, 45:545\u2013552.","journal-title":"Cancer"},{"key":"26_CR7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0733-8619(18)30262-7","volume":"9","author":"LD Recht","year":"1991","unstructured":"Recht LD: Neurologic complications of systemic lymphoma. Neurol Clin 1991, 9:1001\u20131015.","journal-title":"Neurol Clin"},{"key":"26_CR8","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1212\/WNL.49.6.1728","volume":"49","author":"MC Chamberlain","year":"1997","unstructured":"Chamberlain MC, Kormanik PA: Non-AIDS-related lymphomatous meningitis: combined modality therapy. Neurology 1997, 49:1728\u20131731.","journal-title":"Neurology"},{"key":"26_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V47.1.3.3","volume":"47","author":"PA Bunn","year":"1976","unstructured":"Bunn PA, Schein PS, Banks PM, et al.: Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisited. Blood 1976, 47:3\u201310.","journal-title":"Blood"},{"key":"26_CR10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/10428199909058415","volume":"32","author":"PL Zinzani","year":"1999","unstructured":"Zinzani PL, Magagnoli M, Frezza G, et al.: Isolated central nervous system relapse in aggressive non-Hodgkin\u2019s lymphoma: the Bologna experience. Leuk Lymphoma 1999, 32:571\u2013576. luates frequency of CNS relapse in 175 patients with aggressive NHL who had attained CR with systemic chemotherapy but had not received prophylaxis.","journal-title":"Leuk Lymphoma"},{"key":"26_CR11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(71)90239-7","volume":"51","author":"JW Griffin","year":"1971","unstructured":"Griffin JW, Thompson RW, Mitchinson MJ, et al.: Lymphomatous leptomeningitis. Am J Med 1971, 51:200\u2013208.","journal-title":"Am J Med"},{"key":"26_CR12","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/cncr.10699","volume":"95","author":"N Tomita","year":"2002","unstructured":"Tomita N, Kodama F, Kanamori H, et al.: Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-Hodgkin lymphoma. Cancer 2002, 95:576\u2013580. ospective analysis regarding the incidence of CNS recurrence after CR and the influence of prophylactic intrathecal methotrexate and hydrocortisone.","journal-title":"Cancer"},{"key":"26_CR13","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/annonc\/mdf175","volume":"13","author":"A Hollender","year":"2002","unstructured":"Hollender A, Kvaloy S, Nome O, et al.: Central nervous system involvement following diagnosis of non-Hodgkin\u2019s lymphoma: a risk model. Ann Oncol 2002, 13:1099\u20131107. rospective study of risk factors for CNS involvement in 2514 NHL patients without such involvement at diagnosis. The study proposes a risk model to guide clinicians in identifying high-risk patients and the use of CNS prophylaxis.","journal-title":"Ann Oncol"},{"key":"26_CR14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0733-8619(18)30252-4","volume":"9","author":"SA Grossman","year":"1991","unstructured":"Grossman SA, Moynihan TJ: \u2018Neoplastic meningitis\u2019: neurologic complications of systemic cancer. Neurol Clin 1991, 9:843\u2013856.","journal-title":"Neurol Clin"},{"key":"26_CR15","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/1042819031000067909","volume":"44","author":"R Buckstein","year":"2003","unstructured":"Buckstein R, Lim W, Franssen E, et al.: CNS prophylaxis and treatment in non-Hodgkin\u2019s lymphoma: variation in practice and lessons from the literature. Leuk Lymphoma 2003, 44:955\u2013962.","journal-title":"Leuk Lymphoma"},{"key":"26_CR16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1600-0609.1985.tb02817.x","volume":"35","author":"J Ersboll","year":"1985","unstructured":"Ersboll J, Schultz HB, Thomsen BLR, et al.: Meningeal involvement in non-Hodgkin\u2019s lymphoma: symptoms, incidence, risk factors and treatment. Scand J Hematol 1985, 35:487\u2013496.","journal-title":"Scand J Hematol"},{"key":"26_CR17","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood.V91.4.1178","volume":"91","author":"K Besien van","year":"1998","unstructured":"van Besien K, Ha CS, Murphy S, et al.: Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood 1998, 91:1178\u20131184.","journal-title":"Blood"},{"key":"26_CR18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0950-3536(96)80050-3","volume":"9","author":"ID Horak","year":"1996","unstructured":"Horak ID, Kremer AB, Magrath IT: Management of histologically aggressive lymphomas with a high risk of CNS disease. Baillieres Clin Hematol 1996, 9:707\u2013726.","journal-title":"Baillieres Clin Hematol"},{"key":"26_CR19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/A:1008260120532","volume":"9","author":"GM Bos","year":"1998","unstructured":"Bos GM, van Putten WLJ, van der Holt B, et al.: For which patients with aggressive non-Hodgkin\u2019s lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON Group. Ann Oncol 1998, 9:191\u2013194. Analyzed risk of CNS relapse in 193 patients with NHL who had achieved CR with conclusion that no subgroup could be discriminated in which prophylactic treatment would be of substantial benefit.","journal-title":"Ann Oncol"},{"key":"26_CR20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0090-3019(99)00186-X","volume":"53","author":"S Yoshida","year":"2000","unstructured":"Yoshida S, Morii K, Watanabe M, et al.: Characteristic features of malignant lymphoma with central nervous system involvement. Surg Neurol 2000, 53:163\u2013167.","journal-title":"Surg Neurol"},{"key":"26_CR21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0002-9343(88)90262-8","volume":"84","author":"L Recht","year":"1988","unstructured":"Recht L, Straus DJ, Cirrincione C, et al.: Central nervous system metastases from non-Hodgkin\u2019s lymphoma: treatment and prophylaxis. Am J Med 1988, 84:425\u2013435.","journal-title":"Am J Med"},{"key":"26_CR22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1023\/A:1008394827806","volume":"11","author":"C Haioun","year":"2000","unstructured":"Haioun C, Besson C, Lepage E, et al.: Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin\u2019s lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients. Ann Oncol 2000, 11:685\u2013690.","journal-title":"Ann Oncol"},{"key":"26_CR23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0733-8619(02)00032-4","volume":"21","author":"S Kesari","year":"2003","unstructured":"Kesari S, Batchelor T: Leptomeningeal metastases. Neurol Clin 2003, 21:25\u201366.","journal-title":"Neurol Clin"},{"key":"26_CR24","first-page":"1363","volume-title":"Lymphoma of the Nervous System","author":"P Giglio","year":"2004","unstructured":"Giglio P, Gilbert M: Neurological complications of non-Hodgkin\u2019s lymphoma. In Lymphoma of the Nervous System. Edited by Batchelor T. St. Louis, MO: Elsevier; 2004:1363\u20131369."},{"key":"26_CR25","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood.V54.6.1249.1249","volume":"54","author":"JP Litam","year":"1979","unstructured":"Litam JP, Cabanillas F, Smith TL, et al.: Central nervous system relapse in malignant lymphomas: risk factors and implications for prophylaxis. Blood 1979, 54:1249\u20131257.","journal-title":"Blood"},{"key":"26_CR26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1005976926058","volume":"37","author":"MC Chamberlain","year":"1998","unstructured":"Chamberlain MC: Leptomeningeal metastases: a review of evaluation and treatment. J Neurooncol 1998, 37:271\u2013284.","journal-title":"J Neurooncol"},{"key":"26_CR27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1005956925637","volume":"38","author":"LM DeAngelis","year":"1998","unstructured":"DeAngelis LM: Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 1998, 38:245\u2013252.","journal-title":"J Neurooncol"},{"key":"26_CR28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.1993.11.3.561","volume":"11","author":"SA Grossman","year":"1993","unstructured":"Grossman SA, Finkelstein DM, Ruckdeschel JC, et al.: Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. J Clin Oncol 1993, 11:561\u2013569.","journal-title":"J Clin Oncol"},{"key":"26_CR29","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1840::AID-CNCR28>3.0.CO;2-C","volume":"86","author":"J Desai","year":"1999","unstructured":"Desai J, Mitnick RJ, Henry DH, et al.: Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-Hodgkin lymphoma. Cancer 1999, 86:1840\u20131847.","journal-title":"Cancer"},{"key":"26_CR30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archinte.1986.00360160243032","volume":"146","author":"JC Frick","year":"1986","unstructured":"Frick JC, Hansen RM, Anderson T, et al.: Successful high-dose intravenous cytarabine treatment of parenchymal brain involvement from malignant lymphoma. Arch Intern Med 1986, 146:791\u2013792.","journal-title":"Arch Intern Med"},{"key":"26_CR31","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","volume":"17","author":"MJ Glantz","year":"1999","unstructured":"Glantz MJ, LaFollette S, Jaeckle KA, et al.: Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 1999, 17:3110\u20133116. Small randomized study comparing intrathecal liposomal cytarabine with intrathecal cytarabine for lymphomatous meningitis. The authors conclude that the efficacy of liposomal cytarabine is superior to standard cytarabine for the treatment of lymphomatous meningitis.","journal-title":"J Clin Oncol"},{"key":"26_CR32","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.1998.16.4.1561","volume":"16","author":"MJ Glantz","year":"1998","unstructured":"Glantz MJ, Cole BF, Recht L, et al.: High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: Is intrathecal chemotherapy necessary? J Clin Oncol 1998, 16:1561\u20131567.","journal-title":"J Clin Oncol"},{"key":"26_CR33","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/blood-2002-06-1636","volume":"101","author":"JL Rubenstein","year":"2003","unstructured":"Rubenstein JL, Combs D, Rosenberg J, et al.: Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood 2003, 101:466\u2013468.","journal-title":"Blood"},{"key":"26_CR34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1005995127938","volume":"38","author":"PEJ Hanssens","year":"1998","unstructured":"Hanssens PEJ, Lagerwaard FJ, Levendag PC: Principles of radiotherapy of neoplastic meningiosis. J Neuro-oncol 1998, 38:145\u2013150.","journal-title":"J Neuro-oncol"},{"key":"26_CR35","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0360-3016(90)90555-X","volume":"19","author":"JR Gray","year":"1990","unstructured":"Gray JR, Wallner KE: Reversal of cranial nerve dysfunction with radiation therapy in adults with lymphoma and leukemia. Int J Radiat Oncol Biol Phys 1990, 19:439\u2013444.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"26_CR36","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1200\/JCO.1993.11.10.1978","volume":"11","author":"MC Chamberlain","year":"1993","unstructured":"Chamberlain MC, Dirr L: Involved-field radiotherapy and intra-Ommaya methotrexate\/cytarabine in patients with AIDS-related lymphomatous meningitis. J Clin Oncol 1993, 11:1978\u20131984.","journal-title":"J Clin Oncol"},{"key":"26_CR37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1005999228846","volume":"38","author":"T Siegal","year":"1998","unstructured":"Siegal T: Leptomeningeal metastases: rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy. J Neurooncol 1998, 38:151\u2013157.","journal-title":"J Neurooncol"},{"key":"26_CR38","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0002-9343(88)90284-7","volume":"84","author":"PA Burch","year":"1988","unstructured":"Burch PA, Grossman SA: Treatment of epidural cord compressions from Hodgkin\u2019s disease with chemotherapy: a report of 2 cases and a review of the literature. Am J Med 1988, 84:555\u2013558.","journal-title":"Am J Med"},{"key":"26_CR39","unstructured":"Van den Bent MJ: Neurological complications of systemic lymphoma. In Handbook of Clinical Neurology-Neuro-Oncology, part III. Edited by Vecht J. Elsevier Science; 1997: 25 (69):261\u2013287."},{"key":"26_CR40","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1212\/WNL.46.6.1543","volume":"46","author":"ET Wong","year":"1996","unstructured":"Wong ET, Portlock CS, O\u2019Brien JP, et al.: Chemosensitive epidural spinal cord disease in non-Hodgkin\u2019s lymphoma. Neurology 1996, 46:1543\u20131547.","journal-title":"Neurology"},{"key":"26_CR41","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/1097-0142(19861101)58:9<2120::AID-CNCR2820580926>3.0.CO;2-A","volume":"58","author":"R Epelbaum","year":"1986","unstructured":"Epelbaum R, Haim N, Ben-Shahar M, et al.: Non-Hodgkin\u2019s lymphoma presenting with spinal epidural involvement. Cancer 1986, 58:2120\u20132124.","journal-title":"Cancer"},{"key":"26_CR42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0360-3016(86)90094-5","volume":"12","author":"K Aabo","year":"1986","unstructured":"Aabo K, Walbom-Jorgensen S: Central nervous system complications by malignant lymphomas: radiation schedule and treatment results. Int J Radiat Oncol Biol Phys 1986, 12:197\u2013202.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"26_CR43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1385\/1-59259-317-8:371","volume-title":"Cancer Neurology in Clinical Practice","author":"BP O\u2019Neill","year":"2002","unstructured":"O\u2019Neill BP: Neurologic complications of Hodgkin\u2019s disease and the non-Hodgkin\u2019s lymphomas. In Cancer Neurology in Clinical Practice. Edited by Schiff D, Wen PY. Totawa, NJ: Humana Press; 2002:371\u2013384."},{"key":"26_CR44","first-page":"675","volume":"30","author":"MK Lyons","year":"1992","unstructured":"Lyons MK, O\u2019Neill BP, Marsh WR, et al.: Primary spinal epidural non-Hodgkin\u2019s lymphoma: report of eight patients and review of the literature. Neurosurgery 1992, 30:675\u2013680.","journal-title":"Neurosurgery"},{"key":"26_CR45","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3816\/CLM.2001.n.017","volume":"2","author":"T Batchelor","year":"2001","unstructured":"Batchelor T, Leahy N, Kaufman D: High-dose methotrexate for isolated central nervous system relapse in patients with testicular non-Hodgkin\u2019s lymphoma. Clin Lymphoma 2001, 2:116\u2013119.","journal-title":"Clin Lymphoma"},{"key":"26_CR46","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1200\/JCO.1999.17.9.2854","volume":"17","author":"C Tondini","year":"1999","unstructured":"Tondini C, Ferreri AJ, Siracusano L, et al.: Diffuse large-cell lymphoma of the testis. J Clin Oncol 1999, 17:2854\u20132858.","journal-title":"J Clin Oncol"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-005-0026-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-005-0026-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-005-0026-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T16:47:29Z","timestamp":1587574049000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-005-0026-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["26"],"URL":"https:\/\/doi.org\/10.1007\/s11912-005-0026-9","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}